These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25781553)

  • 21. Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue.
    Islam R; Altundag K; Kurt M; Altundag O; Turen S
    Med Hypotheses; 2005; 65(5):1001-2. PubMed ID: 16002233
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications.
    Boonyaratanakornkit V; Pateetin P
    Biomed Res Int; 2015; 2015():140196. PubMed ID: 25866757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of overweight and obesity in selected gynecological malignancies.
    Markowska A; Stanisławiak-Rudowicz J; Jaszczyńska-Nowinka K
    Eur J Gynaecol Oncol; 2017; 38(3):335-341. PubMed ID: 29693868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy.
    Eden JA
    Horm Mol Biol Clin Investig; 2013 Aug; 14(2):57-63. PubMed ID: 25436720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of obesity on mammary gland inflammation and local estrogen production.
    Brown KA
    J Mammary Gland Biol Neoplasia; 2014 Jul; 19(2):183-9. PubMed ID: 24935438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development.
    Qureshi R; Picon-Ruiz M; Aurrekoetxea-Rodriguez I; Nunes de Paiva V; D'Amico M; Yoon H; Radhakrishnan R; Morata-Tarifa C; Ince T; Lippman ME; Thaller SR; Rodgers SE; Kesmodel S; Vivanco MDM; Slingerland JM
    Cell Metab; 2020 Jun; 31(6):1154-1172.e9. PubMed ID: 32492394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
    Khan S; Shukla S; Sinha S; Meeran SM
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.
    Crujeiras AB; Díaz-Lagares A; Carreira MC; Amil M; Casanueva FF
    Free Radic Res; 2013 Apr; 47(4):243-56. PubMed ID: 23409968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.
    Himbert C; Delphan M; Scherer D; Bowers LW; Hursting S; Ulrich CM
    Cancer Prev Res (Phila); 2017 Sep; 10(9):494-506. PubMed ID: 28864539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [OBESITY AND ENDOMETRIAL CARCINOGENESIS].
    Uchikova E; Uchikov P; Parahuleva P
    Akush Ginekol (Sofiia); 2015; 54(9):34-7. PubMed ID: 26863794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer.
    Rose DP; Vona-Davis L
    Biofactors; 2014; 40(1):1-12. PubMed ID: 23857944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional etiology of breast cancer: where are we now, and where are we going?
    de Waard F
    Nutr Cancer; 1982; 4(2):85-9. PubMed ID: 7162997
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of obesity on breast cancer receptor status and prognosis.
    Rose DP; Vona-Davis L
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1091-101. PubMed ID: 19671029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the obesity epidemic on cancer.
    Goodwin PJ; Stambolic V
    Annu Rev Med; 2015; 66():281-96. PubMed ID: 25423596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.